The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study

Published:2021-06-27 Issue:5 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Schultz Nina Haagenrud¹²³,Glosli Heidi⁴⁵,Bjørnsen Stine²,Holme Pål Andre¹²⁶

Affiliation:

1. Department of Haematology Oslo University Hospital Oslo Norway

2. Research Institute of Internal Medicine Oslo University Hospital Oslo Norway

3. Department of Haematology Akershus University Hospital Lørenskog Norway

4. Division of Paediatric and Adolescent Medicine Centre for Rare Disorders Oslo University Hospital Oslo Norway

5. Division of Paediatric and Adolescent Medicine Department of Paediatric Research Oslo University Hospital Oslo Norway

6. Institute of Clinical Medicine University of Oslo Oslo Norway

Funder

Roche

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12561

Reference26 articles.

1. Factor VIII inhibitors in hemophilia A: rationale and latest evidence

2. WFH Guidelines for the Management of Hemophilia, 3rd edition

3. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

4. Randomized comparison of prophylaxis and on‐demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors

5. FEIBAR: mode of action

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A;Journal of Thrombosis and Haemostasis;2024-07

2. Emicizumab promotes factor Xa generation on endothelial cells;Journal of Thrombosis and Haemostasis;2024-06

3. Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia;Thrombosis Research;2024-05

4. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab;Journal of Thrombosis and Haemostasis;2024-01

5. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc;Haematologica;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3